OTC Markets OTCQB - Delayed Quote USD

MustGrow Biologics Corp. (MGROF)

0.7020
0.0000
(0.00%)
At close: May 21 at 4:00:00 PM EDT
Loading Chart for MGROF
  • Previous Close 0.0000
  • Open 0.7350
  • Bid 0.6490 x 40000
  • Ask 0.6910 x 40000
  • Day's Range 0.6869 - 0.7350
  • 52 Week Range 0.4060 - 1.7310
  • Volume 3,000
  • Avg. Volume 841
  • Market Cap (intraday) 36.252M
  • Beta (5Y Monthly) 2.42
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date May 27, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

mustgrow.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MGROF

View More

Performance Overview: MGROF

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MGROF
21.65%
S&P/TSX Composite index (^GSPTSE)
4.95%

1-Year Return

MGROF
5.65%
S&P/TSX Composite index (^GSPTSE)
15.00%

3-Year Return

MGROF
68.09%
S&P/TSX Composite index (^GSPTSE)
27.93%

5-Year Return

MGROF
220.55%
S&P/TSX Composite index (^GSPTSE)
73.59%

Compare To: MGROF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MGROF

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    --

  • Enterprise Value

    32.63M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    127.02

  • Price/Book (mrq)

    23.32

  • Enterprise Value/Revenue

    114.43

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -45.66%

  • Return on Equity (ttm)

    -126.10%

  • Revenue (ttm)

    398.02k

  • Net Income Avi to Common (ttm)

    -4.89M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3M

  • Total Debt/Equity (mrq)

    23.87%

  • Levered Free Cash Flow (ttm)

    -979.68k

Research Analysis: MGROF

View More

Company Insights: MGROF

Research Reports: MGROF

View More

People Also Watch